Oak Associates Funds

Live Oak Health Sciences Fund

Series ID: S000006542
LEI: 5493006TJLEUT3TZCA70
SEC CIK: 1050918
$54.37M Avg Monthly Net Assets
$50.92M Total Assets
$44K Total Liabilities
$50.87M Net Assets
Live Oak Health Sciences Fund is a Mutual Fund in Oak Associates Funds , based in Ohio, United States of America. The fund has one share class and monthly net assets of $54.37M. On June 28th, 2024 it reported 33 holdings, the largest being Mount Vernon Liquid Assets Portfolio, LLC (19.1%), Regeneron Pharmaceuticals, Inc. (5.6%) and Mckesson Corp. (5.5%). Data provided by Fincoded.

Share Classes

Name Class/Contract ID Ticker Monthly Returns (2 years)
Live Oak Health Sciences Fund C000017877 LOGSX Jul 22Aug 22Sep 22Oct 22Nov 22Dec 22Jan 23Feb 23Mar 23Apr 23May 23Jun 23Jul 23Aug 23Sep 23Oct 23Nov 23Dec 23Jan 24Feb 24Mar 2411.48% (Max)-5.35% (Min)

Holdings

From latest NPORT-P, filed June 28th, 2024 for period ending April 30th, 2024. Historic holdings data available from Fincoded.
Name Profile Category Country Value $USD # Shares % of Fund
Amgen, Inc. (Amgen Inc.) Long Equity-common US $2M 9K 4.79
Bio-Rad Laboratories, Inc. Long Equity-common US $905K 3K 1.78
Biogen, Inc. (Biogen Inc) Long Equity-common US $1M 5K 2.11
Cardinal Health, Inc. Long Equity-common US $2M 18K 3.68
Cencora Inc. Long Equity-common US $3M 11K 5.26
Centene Corp. (Centene Corporation) Long Equity-common US $2M 24K 3.40
Cigna Group/The (The Cigna Group) Long Equity-common US $2M 6K 4.35
Danaher Corp. (Danaher Corporation) Long Equity-common US $2M 6K 3.09
Elevance Health, Inc. (Elevance Health Inc.) Long Equity-common US $2M 4K 4.08
Ensign Group, Inc./The (Ensign Group Inc) Long Equity-common US $1M 10K 2.29
Exelixis, Inc. Long Equity-common US $2M 84K 3.87
Gilead Sciences, Inc. Long Equity-common US $894K 14K 1.76
Humana, Inc. (Humana Inc.) Long Equity-common US $1M 4K 2.33
Incyte Corp. (Incyte Corporation.) Long Equity-common US $827K 16K 1.63
Intuitive Surgical, Inc. (Intuitive Surgical Inc.) Long Equity-common US $2M 5K 3.64
Jazz Pharmaceuticals PLC Long Equity-common IE $931K 8K 1.83
Johnson & Johnson Long Equity-common US $1M 8K 2.41
Laboratory Corp of America Holdings Long Equity-common US $1M 7K 2.58
McKesson Corp. Long Equity-common US $3M 5K 5.54
Medtronic PLC Long Equity-common IE $1M 13K 2.00
Merck & Co., Inc. Long Equity-common US $2M 14K 3.55
Molina Healthcare, Inc. Long Equity-common US $2M 5K 3.49
Mount Vernon Liquid Assets Portfolio, LLC Long Short-term investment vehicle US $10M 19.10
Novartis AG Long Equity-common CH $2M 17K 3.28
Prime Solutions 5% 5/1/24 Long Repurchase agreement US $318K 0.63
Progyny, Inc. (Progyny Inc) Long Equity-common KY $1M 37K 2.32
Regeneron Pharmaceuticals, Inc. Long Equity-common US $3M 3K 5.58
Revvity Inc Long Equity-common US $2M 15K 3.02
Stryker Corp. (Stryker Corporation) Long Equity-common US $1M 3K 2.30
Thermo Fisher Scientific, Inc. (Thermo Fisher Scientific Inc) Long Equity-common US $2M 3K 3.77
United Therapeutics Corp. (United Therapeutics Corporation) Long Equity-common US $2M 7K 3.44
UnitedHealth Group, Inc. (UnitedHealth Group Inc.) Long Equity-common US $2M 3K 3.20
Vertex Pharmaceuticals, Inc. (Vertex Pharmaceuticals Incorporated) Long Equity-common US $2M 4K 3.03

Address

Oak Associates Funds
3800 Embassy Parkway
Suite 310
Akron
Ohio
44333-8334
United States of America

Directors

Susan F. Akers
David J. Gruber
Michael R. Shade
James D. Oelschlager
Pauline F. Ramig

Transfer Agents

Ultimus Fund Solutions, LLC

Pricing Services

Intercontinental Exchange, Inc.

Custodians

U.S. Bank, N.A.

Shareholder Servicing Agents

Ultimus Fund Solutions, LLC

Admins

Ultimus Fund Solutions, LLC

Brokers

INSTINET, LLC